Try
SAMSUNG BIOLOGICS CO.,LTD.
207940.KSSouth Korea
38 filed reports · 509 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
38 reports · Mar 2017 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Half Year · 11012DART | 10 | 4,188 | Jun 2017 to Jun 2026 |
| Q1 · 11013DART | 10 | 3,686 | Mar 2017 to Mar 2026 |
| Annual · 11011DART | 9 | 3,127 | Dec 2017 to Dec 2025 |
| Q3 · 11014DART | 9 | 3,557 | Sep 2017 to Sep 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 H1 | 11012 | Jun 30, 2026 | Aug 14, 2026 | 926 | Open |
| FY2026 Q1 | 11013 | Mar 31, 2026 | May 15, 2026 | 767 | Open |
| FY2025 | 11011 | Dec 31, 2025 | May 15, 2026 | 890 | Open |
| FY2025 Q3 | 11014 | Sep 30, 2025 | Nov 14, 2025 | 946 | Open |
| FY2025 H1 | 11012 | Jun 30, 2025 | Aug 14, 2025 | 719 | Open |
| FY2025 Q1 | 11013 | Mar 31, 2025 | May 15, 2025 | 644 | Open |
| FY2024 | 11011 | Dec 31, 2024 | Aug 14, 2025 | 588 | Open |
| FY2024 Q3 | 11014 | Sep 30, 2024 | Nov 14, 2024 | 732 | Open |
| FY2024 H1 | 11012 | Jun 30, 2024 | Aug 14, 2024 | 707 | Open |
| FY2024 Q1 | 11013 | Mar 31, 2024 | May 16, 2024 | 626 | Open |
| FY2023 | 11011 | Dec 31, 2023 | Mar 7, 2024 | 768 | Open |
| FY2023 Q3 | 11014 | Sep 30, 2023 | Nov 14, 2023 | 368 | Open |
Financial data
509 concepts · 14,558 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
IFRS494 concepts · 13,698 facts · Dec 2015 to Jun 2026
- Stockholders Equity122 · Dec 2015 to Jun 2026
- Accounts Payable116 · Dec 2015 to Jun 2026
- Capital surplus116 · Dec 2015 to Jun 2026
- Cash and Equivalents116 · Dec 2015 to Jun 2026
- Inventory116 · Dec 2015 to Jun 2026
- Long-term trade and other non-current payables116 · Dec 2015 to Jun 2026
- Other Comprehensive income/loss accumulated amount116 · Dec 2015 to Jun 2026
- Property, Plant & Equipment, Net116 · Dec 2015 to Jun 2026
- Retained Earnings (Accumulated Deficit)116 · Dec 2015 to Jun 2026
- Total Assets116 · Dec 2015 to Jun 2026
- Total Current Assets116 · Dec 2015 to Jun 2026
- Total Current Liabilities116 · Dec 2015 to Jun 2026
- Total Equity and Liabilities116 · Dec 2015 to Jun 2026
- Total Liabilities116 · Dec 2015 to Jun 2026
- Total Noncurrent Assets116 · Dec 2015 to Jun 2026
- Total Noncurrent Liabilities116 · Dec 2015 to Jun 2026
- Trade and Other Current Receivables116 · Dec 2015 to Jun 2026
- Other Noncurrent Financial Assets114 · Dec 2015 to Jun 2026
- Issued Share Capital111 · Dec 2016 to Jun 2026
- Long-term deposits not classified as cash equivalents111 · Dec 2016 to Jun 2026
- Other Current Financial Assets111 · Dec 2016 to Jun 2026
- Cost of Revenue110 · Dec 2015 to Jun 2026
- Finance Income110 · Dec 2015 to Jun 2026
- Gross Profit110 · Dec 2015 to Jun 2026
Segment15 concepts · 860 facts · Dec 2022 to Jun 2026
- Revenue329 · Dec 2022 to Jun 2026
- Cost of Revenue88 · Dec 2022 to Jun 2026
- Depreciation, property, plant and equipment57 · Dec 2022 to Jun 2026
- Operating Income57 · Dec 2022 to Jun 2026
- Amortisation, intangible assets other than goodwill45 · Dec 2023 to Jun 2026
- Additions to non-current assets other than financial instruments, deferred tax assets, net defined benefit assets, and rights arising under insurance contracts41 · Dec 2023 to Jun 2026
- Internal revenue36 · Dec 2022 to Sep 2025
- Revenue, Gross36 · Dec 2022 to Sep 2025
- Investments Accounted for Using the Equity Method35 · Dec 2023 to Jun 2026
- Total Assets35 · Dec 2023 to Jun 2026
- Total Liabilities35 · Dec 2023 to Jun 2026
- Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts26 · Dec 2023 to Jun 2026
- Amortisation, intangible assets other than goodwill excluding depreciation of government subsidies24 · Dec 2022 to Sep 2024
- Non-current assets excluding the acquisition of rights arising from financial instruments, deferred tax assets, retirement benefit assets, and insurance contracts8 · Dec 2023 to Sep 2024
- Non-current assets excluding the acquisition of rights arising from financial instruments, deferred tax assets, retirement benefit assets, and insurance contracts8 · Dec 2022 to Mar 2024
Segments
860 factsFigures broken down by business line, region, product or another axis the company reports on.
Segments7 members · 300 facts
- CdmoMemberOfSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember76 · Dec 2022 to Sep 2025
- DevelopmentAndCommercializationOfBiopharmaceuticalsMemberOfSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember76 · Dec 2022 to Sep 2025
- CdmoMemberOfReportableSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember48 · Dec 2024 to Jun 2026
- BiopharmaceuticalDevelopmentAndCommercializationMemberOfSegmentsMemberOfDisclosureOfAssetsAndLiabilitiesForOperatingSegmentsTitleTableOfMember34 · Dec 2023 to Sep 2025
- CdmoMemberOfSegmentsMemberOfDisclosureOfAssetsAndLiabilitiesForOperatingSegmentsTitleTableOfMember34 · Dec 2023 to Sep 2025
- CdmoMemberOfReportableSegmentsMemberOfDisclosureOfAssetsAndLiabilitiesForOperatingSegmentsTableOfMember24 · Dec 2024 to Jun 2026
- BiopharmaceuticalDevelopmentAndCommercializationMemberOfReportableSegmentsMemberOfDisclosureOfAssetsAndLiabilitiesForOperatingSegmentsTableOfMember8 · Dec 2024 to Dec 2025
Geographical areas7 members · 226 facts
- CountryOfDomicileMember65 · Dec 2022 to Jun 2026
- OtherCountriesMember44 · Dec 2022 to Jun 2026
- AmericasMemberOfForeignCountriesMemberOfDisclosureOfGeographicalAreasTableOfMember40 · Dec 2022 to Mar 2026
- EuropeMemberOfForeignCountriesMemberOfDisclosureOfGeographicalAreasTableOfMember40 · Dec 2022 to Mar 2026
- ForeignCountriesMember21 · Dec 2022 to Jun 2026
- AmericasMember8 · Jun 2025 to Jun 2026
- EuropeMember8 · Jun 2025 to Jun 2026
Products and services2 members · 176 facts
- OtherRevenueMemberOfProductsAndServicesMemberOfDisclosureOfProductsAndServicesTableOfMember88 · Dec 2022 to Jun 2026
- RevenueFromSaleOfGoodsProductMemberOfProductsAndServicesMemberOfDisclosureOfProductsAndServicesTableOfMember88 · Dec 2022 to Jun 2026
Segment consolidation items2 members · 158 facts
- OperatingSegmentsMember134 · Dec 2022 to Jun 2026
- EliminationOfIntersegmentAmountsMember24 · Dec 2024 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.